163
Participants
Start Date
April 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Fostamatinib
Fostamatinib 100mg twice daily for 12 weeks
Fostamatinib
Fostamatinib 100mg twice daily for 4 weeks, followed by150mg once daily up to Week 12
Fostamatinib
Fostamatinib 75mg twice daily for 12 weeks
Fostamatinib
Fostamatinib 50mg twice daily for 12 weeks
Placebo
Placebo twice daily for 12 weeks
Research Site, New Territories
Research Site, Hong Kong
Research Site, Matsuyama
Research Site, Fukuoka
Research Site, Kitakyushu-shi
Research Site, Kurume
Research Site, Sapporo
Research Site, Kato-shi
Research Site, Kasama-shi
Research Site, Kumamoto
Research Site, Sendai
Research Site, Isahaya
Research Site, Nagasaki
Research Site, Omura-shi
Research Site, Sasebo-shi
Research Site, Shibata
Research Site, Okayama
Research Site, Tomigusuku-shi
Research Site, Matsue
Research Site, Hamamatsu
Research Site, Shinjuku
Research Site, tabashi City
Research Site, Anyang-si
Research Site, Gwangju
Research Site, Incheon
Research Site, Seoul
Research Site, Chiayi City
Research Site, Kaohsiung City
Research Site, Taichung
Research Site, Taipei
Research Site, Bangkok
Research Site, Singapore
Research Site, Hanoi
Research Site, Ho Chi Minh City
Lead Sponsor
AstraZeneca
INDUSTRY